ConductScience.org, home
Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye
API referenceFor AI assistants

Trial · NCT04423718

Participant flow21

How many started, completed or left each group, period by period.

1 to 20 of 21

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Main StudySTARTEDAflibercept 2q8 (Week 0-96) / HD (up to Week 156)336
Main StudySTARTEDAflibercep HDq12 (Week 0-156)335
Main StudySTARTEDAflibercept HDq16 (Week 0-156)338
Main StudyCOMPLETEDAflibercept 2q8 (Week 0-96) / HD (up to Week 156)286
Main StudyCOMPLETEDAflibercep HDq12 (Week 0-156)291
Main StudyCOMPLETEDAflibercept HDq16 (Week 0-156)292
Main StudyNOT COMPLETEDAflibercept 2q8 (Week 0-96) / HD (up to Week 156)50
Main StudyNOT COMPLETEDAflibercep HDq12 (Week 0-156)44
Main StudyNOT COMPLETEDAflibercept HDq16 (Week 0-156)46
Extension PhaseSTARTEDAflibercept 2q8 (Week 0-96) / HD (up to Week 156)208
Extension PhaseSTARTEDAflibercep HDq12 (Week 0-156)210
Extension PhaseSTARTEDAflibercept HDq16 (Week 0-156)207
Extension PhaseTreatedAflibercept 2q8 (Week 0-96) / HD (up to Week 156)208
Extension PhaseTreatedAflibercep HDq12 (Week 0-156)210
Extension PhaseTreatedAflibercept HDq16 (Week 0-156)207
Extension PhaseCOMPLETEDAflibercept 2q8 (Week 0-96) / HD (up to Week 156)187
Extension PhaseCOMPLETEDAflibercep HDq12 (Week 0-156)186
Extension PhaseCOMPLETEDAflibercept HDq16 (Week 0-156)191
Extension PhaseNOT COMPLETEDAflibercept 2q8 (Week 0-96) / HD (up to Week 156)21
Extension PhaseNOT COMPLETEDAflibercep HDq12 (Week 0-156)24

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04423718/flow

API referenceFor AI assistants